The I148M polymorphism results in a critical amino acid change next to PNPLA3’s catalytic domain, likely reducing substrate access and reducing enzymatic activity towards glycerolipids, thereby leading to the development of macrovescicular steatosis [12], [19]. The gene discussed is PNPLA3; the disease is steatosis.